Engineered microbial living matter for diagnostics, prevention, and therapy
Current Opinion in Biotechnology · 2025-04 · 92 · 103269
DOI: 10.1016/j.copbio.2025.103269 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2025-04. Verfasst von Ali Khazem und 4 weiteren Autor:innen. Beteiligte Einrichtung: INM - Leibniz Institute for New Materials, Saarbrücken, Germany. Hauptthemen laut MEDLINE: Microorganisms, Genetically-Modified. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Research Council, European Innovation Council, European Commission.
Abstract (Originalsprache)
Living therapeutic and diagnostic materials based on engineered microorganisms are emerging as a novel approach with the perspective of providing patient-tailored, sustainable, and cost-effective healthcare solutions. In this review, we focus on recent advances in using genetically or chemically engineered microorganisms as living diagnostics, therapeutics, and as a means of prevention for various diseases. We also highlight the applications of living therapeutics for acute and chronic diseases, and the role of micro/macro-encapsulation of the engineered microorganisms. We further showcase the current success of engineered living therapeutics in clinical trials and discuss challenges and future trends in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- INM - Leibniz Institute for New Materials, Saarbrücken, Germany.
- INM - Leibniz Institute for New Materials, Saarbrücken, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
- INM - Leibniz Institute for New Materials, Saarbrücken, Germany; Saarland University, Department of Materials Science and Engineering, Saarbrücken, Germany.
- INM - Leibniz Institute for New Materials, Saarbrücken, Germany; Saarland University, Department of Materials Science and Engineering, Saarbrücken, Germany. Electronic address: Wilfried.Weber@leibniz-inm.de.
Förderung
- HORIZON EUROPE European Research Council
- European Innovation Council
- European Commission
- European Research Council
- Federal Ministry of Education and Research Bonn Office
Zitieren
APA
Khazem, A., Schmachtenberg, R., Weiand, A., Sankaran, S., & Weber, W. (2025). Engineered microbial living matter for diagnostics, prevention, and therapy. Current Opinion in Biotechnology, 92, 103269. https://doi.org/10.1016/j.copbio.2025.103269
Vancouver
Khazem A, Schmachtenberg R, Weiand A, Sankaran S, Weber W. Engineered microbial living matter for diagnostics, prevention, and therapy. Current Opinion in Biotechnology. 2025;92:103269. doi:10.1016/j.copbio.2025.103269
BibTeX
@article{Khazem2025,
author = {Khazem, Ali and Schmachtenberg, Rosanne and Weiand, Anke and Sankaran, Shrikrishnan and Weber, Wilfried},
title = {Engineered microbial living matter for diagnostics, prevention, and therapy},
journal = {Current Opinion in Biotechnology},
year = {2025},
volume = {92},
pages = {103269},
doi = {10.1016/j.copbio.2025.103269}
}
EUVIMED